WOAG
WITHDRAWAL OF ATTORNEY GRANTED
10/13/2025
Back to search
Official data from USPTO
PRORELIX RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
04/03/2026
Trademark type
Combined
Nice classes
42, 44
Filing date
05/04/2022
Registration date
05/14/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/14/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
08/04/2017
First use in commerce
08/04/2017
Drawing code
3
Owner type
01
Owner location
Kad Nagar, Undri Pune,, IN
Examiner
CHISOLM, KEVON
Law office
L30
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "ProRelix RESEARCH" wherein the word 'Pro' is written in white contained within two green overlapping squares and the word 'Relix' written in dark green color and 'RESEARCH' written in green color to the right of the squares. The grey background is not a feature of the mark.
Holders and representatives
Holders
N. A. (pessoa física)
Representatives
Niranjan Narendra Andhalkar
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Clinical research in the field of PharmaBiotechBiopharmaMedical devicesNutraceutical and Herbal domain; Development of pharmaceutical preparations and medicines; Information technology consulting services; Pharmaceutical drug development services; Pharmaceutical research services; Research and development and consultation related thereto in the field of PharmaBiotechBiopharmaMedical devicesNutraceutical and Herbal domain; Research and development in the field of PharmaBiotechBiopharmaMedical devicesNutraceutical and Herbal domain; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of technology in the field of PharmaBiotechBiopharmaMedical devicesNutraceutical and Herbal domain; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Basic and clinical research in the field of respiratory science and medicine; Biochemical research and development; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Consulting in the field of information technology; Laboratory research services relating to pharmaceuticals; Medical and scientific researchconducting clinical trials for others; Outsource service provider in the field of information technology consulting; Outsource service providers in the field of information technology; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research and development; Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of PharmaBiotechBiopharmaMedical devicesNutraceutical and Herbal domain; Testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy
Class 44
Pharmaceutical compounding services
Publications
History of USPTO decisions and trademark events.
31 publications found
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
10/13/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/14/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/14/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2024
PUBO
PUBLISHED FOR OPPOSITION
02/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/22/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/20/2023
ALIE
ASSIGNED TO LIE
12/20/2023
NREV
NOTICE OF REVIVAL - E-MAILED
07/25/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/25/2023
PETG
PETITION TO REVIVE-GRANTED
07/25/2023
PROA
TEAS PETITION TO REVIVE RECEIVED
07/25/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/28/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/28/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/28/2023
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
06/21/2023
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
06/21/2023
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
06/15/2023
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
06/15/2023
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
06/15/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/23/2023
GNRT
NON-FINAL ACTION E-MAILED
02/23/2023
CNRT
NON-FINAL ACTION WRITTEN
02/23/2023
DOCK
ASSIGNED TO EXAMINER
02/22/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/10/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/09/2022
NWAP
NEW APPLICATION ENTERED
05/07/2022
Continuous trademark protection
Get notified about every new filing that threatens PRORELIX RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.